- Home
- EXAS vs FYBR Comparison
EXAS vs FYBR Comparison
Compare EXAS & FYBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXAS | FYBR |
|---|---|---|
| Founded | 1995 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EXAS | FYBR |
|---|---|---|
| Price | $101.54 | $38.00 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 20 | 2 |
| Target Price | ★ $77.94 | N/A |
| AVG Volume (30 Days) | ★ 10.8M | 1.9M |
| Earning Date | 11-03-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,082,033,000.00 | ★ $6,106,000,000.00 |
| Revenue This Year | $19.40 | $5.86 |
| Revenue Next Year | $13.51 | $3.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.47 | 4.25 |
| 52 Week Low | $38.81 | $34.52 |
| 52 Week High | $101.95 | $38.05 |
Technical Indicators
Market Signals| Indicator | EXAS | FYBR |
|---|---|---|
| Relative Strength Index (RSI) | 89.64 | 58.04 |
| Support Level | $100.95 | $37.88 |
| Resistance Level | $101.95 | $38.05 |
| Average True Range (ATR) | 0.34 | 0.10 |
| MACD | -0.87 | -0.01 |
| Stochastic Oscillator | 59.71 | 84.48 |
Price Performance
Historical ComparisonAbout EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About FYBR Frontier Communications Parent Inc.
Frontier Communications Parent Inc is a communications and technology provider offering broadband services. The company provides voice services, including data-based voice over Internet protocol (VoIP) and unified communications as a service (UCaaS), as well as long-distance and voice messaging services, to consumer and business customers in all its markets.